| Product NDC: | 43288-250 |
| Proprietary Name: | ORAVIG |
| Non Proprietary Name: | miconazole |
| Active Ingredient(s): | 50 mg/1 & nbsp; miconazole |
| Administration Route(s): | BUCCAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43288-250 |
| Labeler Name: | Praelia Pharmaceuticals Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022404 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121101 |
| Package NDC: | 43288-250-14 |
| Package Description: | 1 BOTTLE in 1 CARTON (43288-250-14) > 14 TABLET in 1 BOTTLE |
| NDC Code | 43288-250-14 |
| Proprietary Name | ORAVIG |
| Package Description | 1 BOTTLE in 1 CARTON (43288-250-14) > 14 TABLET in 1 BOTTLE |
| Product NDC | 43288-250 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | miconazole |
| Dosage Form Name | TABLET |
| Route Name | BUCCAL |
| Start Marketing Date | 20121101 |
| Marketing Category Name | NDA |
| Labeler Name | Praelia Pharmaceuticals Inc |
| Substance Name | MICONAZOLE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |